In the April issue of Mayo Clinic Proceedings, researchers from the USA's Mayo Clinic Arizona and Arizona State University suggest that the mix of the trillions of bacteria that populate the human gastrointestinal tract - gut microbiota - are involved in regulating weight and that modifying them could one day be a treatment option for obesity.
One study cited by the authors observed that young, conventionally-reared mice have significantly higher body fat content than a laboratory-bred, germ-free strain of mice that lack these bacteria, despite consuming less food than their germ-free counterparts. When gut microbiota from normal mice were transplanted into germ-free mice, they experienced a 60% increase in body fat within two weeks, without any increase in food consumption or differences in energy expenditure. Another animal study reviewed by the authors focused on the gene content of the gut microbiota in mice. Finding more end products of fermentation and fewer calories in the feces of obese mice led researchers to speculate that the gut microbiota in the obese mice help extract additional calories from ingested food.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze